Acute Myeloid Leukemia, Pediatric: Clinical Trials

3 trials for Acute Myeloid Leukemia, Pediatric, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Terminated 1
Phase 21Recruiting 1

Follow Acute Myeloid Leukemia, Pediatric: new trials by email Literature Review of Acute Myeloid Leukemia, Pediatric trials Research Report on Acute Myeloid Leukemia, Pediatric

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
Rabbit Anti thymocyte globulin, Busulfan, Fludarabine - AML, Childhood, Aml
Phase 1 / Phase 2RecruitingWashington University School of Medicine682024-11-152026-08-24
CD123 Redirected T Cells for AML in Pediatric Subjects
CART123 cells; cyclophosphamide; fludarabine - Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, Pediatric
Phase 1TerminatedUniversity of Pennsylvania122021-04-022025-10-15
Efficacy Analysis of Comparison of CAMS(Chinese Academy of Medical Sciences)-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia
Risk-stratified therapy - Acute Myeloid Leukemia, Pediatric
CompletedInstitute of Hematology & Blood Diseases Hospital, China3202005-04-102026-02-11

Narrower conditions

Leukemia, Myeloid, Acute (3)  ·  Leukemia (1)  ·  Recurrence (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Leukemia, Myeloid (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Leukemia (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

fludarabine (2)  ·  Antilymphocyte Serum (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Interleukin-2 (1)  ·  Melphalan (1)  ·  Receptors, Antigen, T-Cell, alpha-beta (1)  ·  Thiotepa (1)  ·  plerixafor (1)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (1)  ·  University of Pennsylvania (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)  ·  China (1)

Top investigators

Thomas M Pfeiffer, M.D. (1)  ·  Zhu Xiaofan (1)